Online citations, reference lists, and bibliographies.
← Back to Search

Phosphatidate Accumulation In Hormone-treated Hepatocytes Via A Phospholipase D Mechanism.

S. Bocckino, P. F. Blackmore, P. Wilson, J. Exton
Published 1987 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Isolated rat hepatocytes responded to a variety of Ca2+-mobilizing agents (vasopressin, angiotensin II, epinephrine, epidermal growth factor, ATP, and ADP) with a rapid increase in phosphatidate mass, as measured by a sensitive new method. When hepatocytes were incubated with vasopressin (10(-8) M), phosphatidate levels increased 2-3-fold in 2 min, but there was no significant increase in diacylglycerol at this time. Changes in the fatty acid composition of phosphatidate also preceded those in diacylglycerol. De novo synthesis of phosphatidate from [3H]glycerol was unaffected by vasopressin in short-term incubation. Incubation of washed rat liver plasma membranes with GTP gamma S caused a time-dependent increase in phosphatidate. When membranes were incubated with GTP gamma S and [gamma-32P]ATP, no incorporation of 32P into phosphatidate was observed. This excludes the phospholipase C-diacylglycerol kinase pathway and suggests that a phospholipase D activity produced the phosphatidate. At submaximal concentrations of GTP gamma S, ATP and ADP stimulated membrane phosphatidate formation, presumably by acting through P2-purinergic receptors. Only phosphatidylcholine, among the major phospholipids, decreased in the membranes in response to GTP gamma S. The fatty acid composition of the phosphatidate produced in response to vasopressin in hepatocytes also suggests that phosphatidylcholine may be the source of hormonally elicited phosphatidate. We conclude that Ca2+-mobilizing hormones mainly increase phosphatidate levels in hepatocytes by a mechanism that does not involve phosphorylation of diacylglycerol or de novo synthesis but involves a guanine nucleotide-binding protein coupled to phospholipase D.



This paper is referenced by
10.1016/0006-291X(89)92407-8
Mass determination of receptor-mediated accumulation of phosphatidate and diglycerides in human neutrophils measured by Coomassie blue staining and densitometry.
D. E. Agwu (1989)
10.1128/IAI.58.3.761-765.1990
Protein phosphorylation by protein kinase C in HEp-2 cells infected with enteropathogenic Escherichia coli.
T. Baldwin (1990)
10.1016/0925-4439(92)90094-4
Phospholipase D signaling in ischemic heart.
I. Moraru (1992)
10.1016/B978-0-12-524155-7.50011-2
5 – Signal Transduction during Exocytosis in Mast Cells
W. Koopmann (1993)
10.1016/S0950-3552(05)80186-5
The endometrium: prostaglandins and intracellular signalling at implantation.
A. Ahmed (1992)
10.1016/0005-2760(89)90206-3
Regulation of the biosynthesis of triacylglycerol, phosphatidylcholine and phosphatidylethanolamine in the liver.
L. Tijburg (1989)
10.1016/0014-5793(89)81457-7
Differential activation by fMet‐Leu‐Phe and phorbol ester of a plasma membrane phosphatidylcholine‐specific phospholipase D in human neutrophil
P. Gelas (1989)
10.1016/0014-5793(89)81782-X
Alcohols selectively stimulate phospholipase D‐mediated hydrolysis of phosphatidylethanolamine in NIH 3T3 cells
Z. Kiss (1989)
10.1210/EDRV.19.1.0322
Nongenomic actions of steroid hormones in reproductive tissues.
A. Revelli (1998)
10.1016/S0002-9629(15)40871-7
Intracellular Phospholipid Signaling Systems
Robert V Farese (1988)
10.1016/0005-2760(89)90299-3
Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils.
M. Rosenthal (1989)
10.1016/0092-8674(93)90323-I
ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity
H. A. Brown (1993)
10.1210/ENDO-126-2-899
Effects of phosphatidic acid on parathyroid hormone release, intracellular free Ca2+, and inositol phosphates in dispersed bovine parathyroid cells.
J. McGhee (1990)
10.1016/0005-2760(94)90186-4
Phosphatidylcholine breakdown and signal transduction.
J. Exton (1994)
A proposed common mechanism by which phorbol esters and epidermal growth factor delay the progression from G2 phase to mitosis of HeLa cells through phospholipid metabolites.
M. Kaszkin (1991)
10.1096/FASEBJ.4.2.2105252
Activation of human neutrophil phospholipase D by three separable mechanisms.
S. Reinhold (1990)
10.1002/EJI.1830220731
Regulation of interleukin‐2 responses by phosphatidic acid
E. Cano (1992)
10.1016/0006-2952(92)90119-4
Inhibition of platelet activation by tyrosine kinase inhibitors.
F. Rendu (1992)
10.1016/0143-4179(89)90089-9
Importance of the presence of the N-terminal tripeptide of substance P for the stimulation of phosphatidylinositol metabolism in rat parotid gland: A possible activation of phospholipases C and D
I. Rollandy (1989)
10.1007/978-3-0348-7681-0
Airways Smooth Muscle: Biochemical Control of Contraction and Relaxation
D. Raeburn (1994)
10.1007/BF01208639
Increased phospholipase D activity in human breast cancer
N. Uchida (2005)
10.1016/0303-7207(95)03706-3
Protein kinase C and its substrates
J. Liu (1996)
10.1002/MED.2610130102
Drugs acting on the intracellular signalling system
Y. Nomura (1993)
10.1016/S0006-291X(88)81012-X
Bradykinin stimulates phosphodiesteratic cleavage of phosphatidylcholine in cultured endothelial cells.
T. W. Martin (1988)
10.1016/0304-4157(90)90007-Y
Receptor-effector coupling by G proteins.
L. Birnbaumer (1990)
10.1111/J.1471-4159.1993.TB03262.X
Signal Transduction Pathways Coupled to a P2U Receptor in Neuroblastoma × Glioma (NG108‐15) Cells
Tai-an Lin (1993)
10.1006/BBRC.1996.5965
Transforming growth factor beta increases the activity of phosphatidate phosphohydrolase-1 in rat hepatocytes.
M. C. Dixon (1997)
Phospholipase D in heart: basal activity and stimulation by phorbol esters and aluminum fluoride
Pharmacology Springer-Verlag (1992)
10.1210/ENDO.137.12.8940366
The activation of phospholipase D participates in the mitogenic action of arginine vasopressin in cultured rat glomerular mesangial cells.
I. Kusaka (1996)
10.1152/AJPCELL.1994.266.4.C1093
Interleukin-1 stimulates phosphatidic acid-mediated phospholipase D activity in human mesangial cells.
S. Bursten (1994)
10.1016/j.plipres.2019.101018
Mammalian phospholipase D: Function, and therapeutics.
M. I. McDermott (2019)
10.1007/BFB0116585
Phospholipase D-structure, regulation and function.
J. Exton (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar